Sutro Biopharma (NASDAQ:STRO – Free Report) had its target price lowered by Wedbush from $20.00 to $12.00 in a report released on Friday, Marketbeat reports. The firm currently has an outperform rating on the stock. Sutro Biopharma Stock Performance NASDAQ:STRO opened at $4.29 on Friday. The stock’s 50 day moving average price is $4.78 and […]
HC Wainwright reissued their buy rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $16.00 target price on the stock. Separately, Wedbush decreased their price target on shares of Sutro Biopharma from $20.00 to $12.00 and set an outperform rating on […]
Sutro Biopharma (NASDAQ:STRO – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.64) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.09, reports. Sutro Biopharma had a negative return on equity of 65.07% and a negative net margin of 250.87%. The company had revenue […]
Sutro Biopharma (NASDAQ:STRO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.64) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.09, reports. The firm had revenue of $10.41 million during the quarter, compared to analyst estimates of $10.45 million. Sutro Biopharma had a negative net […]
Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 1,940,000 shares, a decline of 36.8% from the June 15th total of 3,070,000 shares. Based on an average daily volume of 512,700 shares, […]